Patent foramen ovale closure versus medical therapy for cryptogenic stroke: An updated systematic review and

Sunny Goel1, Shanti Patel1, Elina Zakin2

  • 1Department of Cardiology, Maimonides Medical Center, Brooklyn, NY, 11219, USA.

Indian Heart Journal
|April 7, 2020
PubMed

Insights

Patent foramen ovale (PFO) closure significantly reduces stroke risk in cryptogenic stroke patients compared to medical therapy. However, PFO closure increases the risk of atrial fibrillation.

Area of Science:

  • Cardiology
  • Neurology
  • Interventional Cardiology

Background:

  • The efficacy of patent foramen ovale (PFO) closure for preventing recurrent cryptogenic stroke (CS) remains debated.
  • Medical management is the current standard, but its effectiveness in specific patient subgroups is under investigation.

Purpose of the Study:

  • To compare the safety and efficacy of PFO closure versus medical therapy in patients with CS.
  • To evaluate the impact of PFO closure on stroke recurrence and adverse events.

Main Methods:

  • A systematic review and meta-analysis of randomized control trials (RCTs) were conducted.
  • Searches included PubMed, EMBASE, Cochrane Library, and clinicaltrials.gov.
  • Forest plots with random-effects models were used to compare event rates.

Main Results:

  • Six RCTs with 3747 patients were analyzed, with follow-up ranging from 2 to 5.9 years.
  • PFO closure significantly reduced stroke risk (RR=0.41) but increased atrial fibrillation risk (RR=5.29).
  • No significant differences were found in major bleeding or mortality; device closure was effective in patients with large shunts.

Conclusions:

  • PFO closure offers a significant stroke risk reduction compared to medical management for CS patients.
  • Increased risk of atrial fibrillation is a key consideration with PFO closure.
  • Device closure efficacy is particularly noted in patients with large shunt sizes.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
182
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
199
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
284
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.0K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
890
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
154